Patents
Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
07/2005
07/21/2005US20050159344 Forming a carboxy-saccharide derivative of the glycopeptide antibiotic that has a substituent containing a dicarboxylic acid in which one of the carboxylic acid groups is coupled with a saccharide
07/21/2005US20050158780 Nucleic acid ligands to the prostate specific membrane antigen
07/21/2005US20050158608 Method for manufacturing a layer lamination integrated fuel cell and the fuel cell itself
07/21/2005US20050158315 Monoclonal antibodies against leukocyte adhesion receptor beta-chain, methods of producing these antibodies and use therefore
07/21/2005US20050158242 Detecting presence of selected cancer by measuring levels of Cancer Specific Genes(CSG) in cells, tissues or bodily fluids and comparing levels with levels of CSG from normal human control, wherein change in measured levels is associated with presence of selected cancer; gynecologic and lung cancers
07/21/2005US20050158241 Novel method of diagnosing, monitoring, staging, imaging and treating various cancers
07/21/2005US20050158239 Perturbed membrane-binding compounds and methods of using the same
07/21/2005CA2551913A1 Autoantibodies utilized as carrier agents for pharmaceutical compounds used in tumor imaging and cancer treatment
07/20/2005EP1554734A1 Stabilized superparamagnetic particles
07/20/2005EP1554575A2 Detection, localization and staging of tumors using labeled activated lymphocytes directed to a tumor specific epitope
07/20/2005EP1553987A1 Method for determining gastric evacuation using a 13c-labelled test meal
07/20/2005EP1553986A1 Conjugates of tc complexes and targeting moieties and their use in mri diagnostic
07/20/2005EP1553985A2 Biphenyls and fluorenes as imaging agents in alzheimer's disease
07/20/2005EP1553965A2 Method of treating tumors
07/20/2005EP1553962A1 Combination chemotherapy with chlorotoxin
07/20/2005EP1553924A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
07/20/2005EP1401467A4 Alpha-fetoprotein peptides and uses thereof
07/20/2005EP0871431B1 Hepatocyte-selective oil-in-water emulsion
07/20/2005CN1642983A Antibodies against of C5aR and use thereof
07/20/2005CN1642978A Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
07/20/2005CN1642580A Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
07/20/2005CN1640498A Magnetic nano radioactive medicine and its preparing method
07/19/2005US6919424 Comprises polypeptide for, diagnosis, detection and treatment of cancer
07/19/2005US6919067 Compositions comprising a tissue glue and therapeutic agents
07/14/2005WO2005063306A1 Assembly of gas-filled microvesicle with active component for contrast imaging
07/14/2005WO2005063305A1 Gas-filled microvesicle assembly for contrast imaging
07/14/2005WO2005063304A2 Poly (l-glutamic acid) paramagnetic material complex and use as a biodegradable mri contrast agent
07/14/2005WO2005041747A3 Stealthy nano agents
07/14/2005WO2005009480A3 Implants containing codrugs
07/14/2005WO2004098535A3 Modified antibodies to prostate-specific membrane antigen and uses thereof
07/14/2005US20050153940 Method for using potassium channel activation for delivering a medicant to an abnormal brain region and/or a malignant tumor
07/14/2005US20050153332 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
07/14/2005US20050152842 Poly (L-glutamic acid) paramagnetic material complex and use as a biodegradable MRI contrast agent
07/14/2005US20050152838 administering to mammals a Sindbis virus comprising gene that code detectable labels, concurrently with anticarcinogenic agents, and analyzing the amount of cancer cells in the body of the mammal
07/14/2005US20050152837 Novel method of diagnosing, monitoring, staging, imaging and treating cancer
07/14/2005US20050152836 Diagnostic markers and pharmacological targets in heart failure and related reagents and methods of use thereof
07/14/2005US20050152835 Technetium-99M glucarate methods of use for monitoring tissues
07/14/2005CA2547024A1 Gas-filled microvesicle assembly for contrast imaging
07/14/2005CA2545362A1 Assembly of gas-filled microvesicle with active component for contrast imaging
07/13/2005EP1552002A2 Aptamer-toxin molecules and methods for using same
07/13/2005EP1551461A2 Azo compounds for type i phototherapy
07/13/2005EP1551452A1 Compositions and methods for therapeutic treatment
07/13/2005CN1639195A Selective targeting of tumor vasculature using antibody molecules
07/13/2005CN1638811A Use of 13C labelled substance for measuring lung function
07/13/2005CN1638807A Avidin dimers effective in increasing the concentration of radioactive biotin in pretargeted radioimmunotherapy
07/13/2005CN1638797A Cancer treatment
07/12/2005US6916961 Compound for use in the prevention and treatment of respiratory and nervous system disorders
07/12/2005US6916930 Radioactive iodine-labeled compound
07/12/2005US6916816 Phenanthryl piperazinyl dicarboxylic acids as selective NMDA receptor modulating agents
07/12/2005US6916460 Macrocyclic chelants for metallopharmaceuticals
07/12/2005CA2283518C Diagnostic agents for pancreatic exocrine function
07/12/2005CA2237218C Amino acid analogs for tumor imaging
07/12/2005CA2094494C A 4-quinolone antibiotic compound as gamma ray scintigraphy diagnostic imaging agent
07/07/2005WO2005061445A1 Methods for carbon isotope labeling synthesis by rhodium-promoted carbonylation via isocyanate using azides and carbon-isotope monoxide
07/07/2005WO2005061009A2 Microparticles for microarterial imaging and radiotherapy
07/07/2005WO2005060683A2 Small peptides for the treatment of alzheimer’s disease and other beta-amyloid protein fibrillogenesis disorders
07/07/2005WO2005060569A2 Tame based chelators and uses thereof
07/07/2005WO2005060375A2 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
07/07/2005WO2004109181A3 Device having a location for holding hyperpolarized inert gas
07/07/2005US20050147692 Methods, compositions and devices for inducing stasis in tissues and organs
07/07/2005US20050147603 Employing nonimmunogenic blood products from patients with autoimmune disease
07/07/2005US20050147591 Methods and compositions for viral enhancement of cell killing
07/07/2005US20050147560 13C glucose breath test for the diagnosis of diabetic indications and monitoring glycemic control
07/07/2005US20050147557 Diagnostic agents for pancreatic exocrine function
07/07/2005CA2800228A1 Small peptides for the treatment of alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders
07/07/2005CA2688944A1 Humanized anti-ngf antibodies
07/07/2005CA2529390A1 Microparticles for microarterial imaging and radiotherapy
07/07/2005CA2522421A1 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like protein
07/06/2005EP1549317A1 Improved imaging agents comprising barbituric acid derivatives
07/06/2005CN1635910A Treatment and diagnosis of macrophage mediated disease
07/06/2005CN1209164C Compositions comprising DNA damaging agents and P53
07/05/2005CA2129663C Biosynthetic binding protein for cancer marker
06/2005
06/30/2005WO2005058376A1 Polymeric micellar complexes and drug delivery vehicles thereof
06/30/2005WO2005058247A2 Method for preparing radiolabeled thymidine having low chromophoric byproducts
06/30/2005WO2005034926A3 Non-invasive system for detecting skin cancer
06/30/2005WO2004083902A3 Multifunctional magnetic nanoparticle probes for intracellular molecular imaging and monitoring
06/30/2005US20050142055 Nitrogen gas comprising carbon monoxide is radiated with a deuteron beam, and [15O]carbon monoxide produced by nuclear reaction is recovered; catalytic oxidation
06/29/2005EP1548027A1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient
06/29/2005EP1547996A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
06/29/2005EP1546373A2 Methods for measuring rates of reserve cholesterol transport in vivo, as an index of anti-atherogenesis
06/29/2005EP1546364A2 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
06/29/2005EP1546204A2 Humanized anti-granulocyte mn-3 antibody and uses thereof
06/29/2005EP1546203A2 Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
06/29/2005EP1546092A2 Agents for imaging and diagnostic methods using them
06/29/2005EP1545705A2 Flexible and/or elastic brachytherapy seed or strand
06/29/2005EP1545630A1 Metal binding precursors for the synthesis of peptide-metal conjugates
06/29/2005EP1545628A2 Biochemical methods for measuring metabolic fitness of tissues or whole organisms
06/29/2005EP1545556A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
06/29/2005EP1545525A2 Radiolabeled neurokinin-1 receptor antagonists
06/29/2005EP1545498A2 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same
06/29/2005EP1545287A2 Vasoregulating compounds and methods of their use
06/29/2005EP1272507B1 Integrin binding peptide derivatives
06/29/2005EP1268497B1 Ternary ligand complexes useful as radiopharmaceuticals
06/29/2005EP0929574B1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS
06/29/2005CN1633309A Method of radio-labelling biomolecules
06/28/2005US6911444 Non-steroidal IL-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors
06/28/2005US6911220 Inactivating mature recipient t cells and introducing into a primate recipient fetal or neonatal thymic tissue from a donor of a different species; restoring thymus dependent ability for progenitors to develop into mature t cells
06/23/2005WO2005057589A2 Multi-purpose automated radiotracer synthesizer
06/23/2005WO2005056058A2 Radiosensitizer conjugate to improve the efficacy of radiolabeled drugs
06/23/2005WO2005037312A3 Binding molecules for the extra-domain b of fibronectin, used for the detection of atherosclerotic plaques